BIOCRYST PHARMACEUTICALS, INC. (BCRX) Operating margin 2016–2025
BIOCRYST PHARMACEUTICALS, INC. (BCRX) operating margin by fiscal year — reported operating income divided by reported revenue.
39.0%FY2025 · since FY2016: -184.4% → 39.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 39.0% | +39.5 pp |
| FY2024 | -0.6% | +30.7 pp |
| FY2023 | -31.3% | +23.5 pp |
| FY2022 | -54.8% | +58.3 pp |
| FY2021 | -113.1% | +868.0 pp |
| FY2020 | -981.1% | -777.5 pp |
| FY2019 | -203.7% | +252.5 pp |
| FY2018 | -456.2% | -228.3 pp |
| FY2017 | -227.9% | -43.5 pp |
| FY2016 | -184.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice